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Abstract
BACKGROUND:Diabetesmellitus (DM) is ametabolic disorder that is associatedwith an increased risk of cardiovascular disease.
Vacciniummyrtillus (bilberry) is a useful plant with antidiabetic properties in traditional medicine. The aim of this study was to
investigate theeﬀectsofbilberryagainstDM.Diabeteswas inducedusing intraperitoneal injectionofalloxan (120mgkg−1 body
weight (BW)). Bilberry powder (2 g d−1) and glibenclamide (positive control; 0.6mgkg−1 BW)were administered for 4weeks fol-
lowingalloxan injection. Serumglucose, insulin, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), very-low-density lipoprotein cholesterol (VLDL-C), triglycerides (TG) and C-reactive protein
(CRP) were determined at baseline and at 2nd and 4th week of the study.
RESULTS: Bilberry supplementation resulted in a signiﬁcant reduction of glucose compared with the diabetic control as
well as glibenclamide treatment. Bilberry elevated insulin, reduced TC, LDL-C, VLDL-C and TG levels, and prevented HDL-C
decline. Serum insulin, TC and LDL-C levels were not aﬀected by glibenclamide, and CRP did not signiﬁcantly change with
either bilberry or glibenclamide. Histological examinations revealed a signiﬁcant elevation of islet size in the bilberry and
glibenclamide-treated groups.
CONCLUSION: Dietary supplementation with bilberry fruits may protect against impaired glucose and lipid metabolism in DM.
© 2015 Society of Chemical Industry
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INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder characterized by
insulin resistance and disturbed lipid and glucose metabolism,
which results in several macro- and microvascular complications.1
Insulin resistance drives visceral free fatty acid ﬂux to the
liver, leading to increased hepatic assembly and secretion of
very-low-density lipoproteins (VLDLs), in particular the larger
VLDL1 subfraction.
2,3 Lipid abnormalities in type 2 DM is charac-
terized by elevated serum triglycerides, reduced concentrations of
high-density lipoproteins (HDLs) and increased formation of small,
dense, low-density lipoprotein (sdLDL) particles.4 Triglyceride-rich
lipoproteins are substrates of the hepatic lipase and transformed
into sdLDL after lipase-mediated triglyceride hydrolysis.5 Cor-
rection of hyperglycemia and hyperlipidemia are integral to
the prevention of vascular complications in diabetic patients.
In recent decades there has been interest in using alternative
therapies for the management of DM. Several plants have been
used in traditional medicine to prevent diabetes and mitigate its
complications.6
Vaccinium myrtillus (bilberry) is a medicinal plant belonging to
the Ericaceae family. It is found in the mountains and forests of
Europe and the northern USA.7 Fruits of this plant have been
used in traditional medicine for the treatment of various diseases,
including fevers, coughs, renal stones, intestinal and liver disor-
ders and stomatitis.8 Pharmacological studies have shown that
bilberry fruit is an eﬀective treatment for ocular disorders such
as retinopathy and vascular disorders.7 There is also evidence for
the antidiabetic and hypoglycemic activity of bilberry fruits.9 Bil-
berry fruits are rich in bioactive phytochemicals such as antho-
cyanins, quercetin and catechins, tannins, vitamins and pectins.10
Total content of phenolic acids in bilberry fruits is 31.7± 0.54mg
100 g−1 fresh weight, and mainly include quercetin, myricetin,
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cafeic acid and p-coumaric acid.11 These phytochemicals are
known topossess antioxidant and antidiabetic actions,makingbil-
berry fruit a potential supplement for DM.7 Given the strong evi-
dence supporting biological activities of bilberry phytochemicals,
the present study aimed to investigate the anti-hyperglycemic and
anti-hyperlipidemic activities of bilberry fruit in an experimentally
induced diabetic rat model.
MATERIALS ANDMETHODS
Measurement of anthocyanin content:
Total anthocyanin content of bilberry fruit was determined using
the pH diﬀerential method, as previously described.12
Plant preparation
Fruits of V. myrtillus were collected in September from Arasbaran,
one of the northern cities of Iran, and identiﬁed at the Medical
Plants Research Center of Shahrekord (voucher no. 202). Fruits
were washed and dried in shade at room temperature (20–22 ∘C)
for 2 weeks.
Experimental design
A total of 32 adult male Wistar rats weighing about 190–240 g
were housed in cages at 24 ∘C, with a 12 h light/dark cycle, and
were given a standard rat chow diet. The experimental protocol
was approved by the Ethics Committee of the Isfahan University of
Medical Sciences (Isfahan, Iran) andwas according to the approved
standards for laboratory animal care.
The animals were allowed 2 weeks for acclimatization. Alloxan
(Sigma Aldrich, USA) was administered intraperitoneally at a sin-
gle dose of 120mg kg−1 body weight (BW) to induce diabetes.
Induction of diabetes was conﬁrmed bymeasuring fasting plasma
glucose levels after 72 h of alloxan injection. Rats with plasma glu-
cose levels> 250mgdL−1 were consideredasdiabetic andused for
the experiments. Animals were randomly divided into four equal
groups (n= 8) as follows: 1 – non-diabetic control rats that were
given a basic diet; 2 – alloxan-induced diabetic control rats given
a basic diet; 3 – alloxan-induced diabetic rats receiving gliben-
clamide intraperitoneally at a dose of 0.6mg kg−1 BW (HakimPhar-
macy, Iran) with basic diet; and 4 – alloxan-induced diabetic rats
receiving bilberry powder at a dose of 2 g d−1 (via gavage) with
basic diet.13 Animals in all groups were treated for 4 weeks. At
the start of experiments and at the end of the 2nd and 4th week
of study, blood samples were collected into EDTA (ethylenedi-
aminetetraacetic acid) tubes and plasma was isolated by centrifu-
gation. After the last blood sampling, animals were sacriﬁced and
each pancreas was removed and ﬁxed in 10% formalin. Sections
were cut and stained by hematoxylin and eosin (H&E) for histolog-
ical examination.
Biochemical analyses
Serum glucose was determined by the glucose oxidase
method using a commercial enzymatic kit (Pars azmoon, Iran).
Serum insulin levels were determined using an enzyme-linked
immunosorbent assay (ELISA) method (Monobind Inc., USA). C-
reactive protein (CRP) was measured in plasma via ELISA
(Diagnostics Biochem Com/ Canada). Lipid proﬁle comprising
total cholesterol, low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C) and triglycerides
was determined using routine enzymatic methods with com-
mercial kits on an autoanalyzer (Hitachi Co., Tokyo, Japan).
VLDL-cholesterol (VLDL-C) levels were calculated using Friede-
wald’s formula.14
Statistical analysis
Data expressed as mean± SE and analyzed using the Statistical
Package for the Social Sciences (SPSS) software program (version
15, SPSS Inc., Chicago, IL, USA). The signiﬁcance level of P< 0.05
was considered for all the analyses. The Kruskal–Wallis test was
used to compare between eﬀects based on time. For multiple
comparison the Mann–Whitney test with Bonferroni correction
was used. To determine the time eﬀect based on each group the
Fridmann test was used. Repeated-measures analysis of variance
(RMANOVA) was used to determine the interaction eﬀect of time
and group.
RESULTS
The ripe bilberry fruits contained 15.5% protein, 30.6% carbohy-
drates, 1.5% total fat, 2% soluble solids, 22.3% nitrogen and 1.4%
calcium. Each 500mgof bilberry fruit powder contained 45± 2mg
of anthocyanins.
Alloxan treatment caused a signiﬁcant elevation of blood glu-
cose, whereas blood glucose remained similar to baseline levels
in the non-diabetic group. Supplementation for 2 and 4 weeks
with bilberry as well as with glibenclamide resulted in a signiﬁcant
reduction of fasting blood glucose compared with the diabetic
control group (Table 1).
Serum insulin levels were signiﬁcantly reduced in the diabetic
group. In contrast, insulin levels in the group receiving gliben-
clamide remained statistically unchanged by the end of the
study. Supplementation with bilberry signiﬁcantly elevated serum
insulin compared with the control diabetic rats (Table 1). Alloxan
treatment had an increasing eﬀect on serum total cholesterol,
LDL-C, triglycerides and VLDL-C concentrations, but all of these
parameters were signiﬁcantly reduced following supplementation
with bilberry powder. In the glibenclamide-treated group, VLDL-C
and triglycerides were the only parameters that were reduced.
Serum HDL-C concentrations were reduced in the diabetic con-
trol group compared to the non-diabetic group, while there was
no change in the groups receiving glibenclamide or bilberry, as
also observed in the non-diabetic control group. Serum CRP con-
centrations did not signiﬁcantly change in any of the study groups
(Table 1).
Histological examination of pancreatic tissues indicated
increased size of Langerhans islets following treatment with
bilberry and glibenclamide compared with the diabetic control
group (Table 2 and Fig. 1).
DISCUSSION
The present study indicated a positive impact of supplementation
with bilberry on metabolic abnormalities induced by alloxan.
Bilberry fruit supplementation could reverse the hyperglycemic
and hyperlipidemic eﬀects of alloxan.
Previous studies have shown that bilberry lowers blood glucose
in both animals15,16 and humans,17 and is useful for the prevention
and treatment of diabetic retinopathy.8
The chemical composition of Vaccinium species includes antho-
cyanins, ﬂavonoids, coumarins, sterols, triterpenoids, pectins and
alkaloids.18,19 Anthocyanins, in particular myrtillin antho-
cyanoside, are some of themost active hypoglycemic constituents
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Table 1. Average levels of biochemical parameters in non-diabetic control, diabetic control, diabetic rats treated with bilberry powder and diabetic
rats treated with glibenclamide (mean± SEM; P< 0.05)
Biochemical factor Time Non-diabetic (n= 8) Diabetic (n= 8) Glibenclamide (n= 8) Bilberry (n= 8) p-value
Fasting blood glucose (mgdL−1) 1 56.00± 16.17 48.80± 2.38 55.50± 4.23 47.57± 6.57 0.200
2 73.20± 10.42 291.00± 70.37* 81.33± 31.40† 74.22± 29.17† 0.008
3 69.71± 16.44 316.40± 66.56*‡ 95.500± 21.09† 83.71± 79.19† 0.002
p-value 0.076 0.015 0.074 0.054
1 2.14± 0.66 1.98± 0.84 2.30± 0.44 1.96± 0.32 0.120
Insulin (μu dL−1) 2 1.92± 0.82 1.21± 0.23 2.25± 1.41 2.11± 0.26 0.078
3 2.23± 0.71 0.83± 0.80*‡ 2.00± 0.05 2.41± 0.33† 0.048
p-value 0.281 0.049 0.673 0.875
LDL- cholesterol (mgdL−1) 1 17.00± 1.41 16.80± 2.28 19.40± 4.50 16.83± 1.94 0.084
2 19.25± 5.37 20.60± 3.04 19.60± 3.84 18.33± 3.77 0.751
3 18.14± 2.73 25.20± 1.64*‡ 21.20± 4.65 17.22± 2.72† 0.007
p-value 0.264 0.028 0.607 0.867
HDL-cholesterol (mgdL)−1 1 54.40± 5.94 60.25± 2.21 59.33± 6.34 52.50± 10.78 0.349
2 51.00± 2.16 52.60± 3.43 60.50± 9.39 54.12± 8.96 0.218
3 51.50± 3.27 34.80± 4.49*‡ 51.66± 10.30 44.85± 9.58 0.009
p-value 0.472 0.018 0.070 0.264
Total cholesterol (mgdL−1) 1 105.40± 11.17 107.80± 13.47 111.66± 18.31 98.60± 9.56 0.191
2 95.00± 14.30 107.75± 11.67 111.83± 22.99 96.33± 31.98 0.433
3 92.28± 7.29 136.20± 23.49*‡ 94.83± 23.03 81.33± 21.34† 0.009
p-value 0.105 0.045 0.115 0.264
Triglyceride (mgdL−1) 1 110.00± 29.81 103.80± 16.78 94.50± 23.33 93.20± 20.58 0.617
2 83.60± 13.63 113.40± 59.18 83.33± 5.92 84.11± 42.40 0.920
3 97.14± 17.9 149.60± 19.13*‡ 47.66± 14.17†‡ 49.12± 21.39†‡ 0.003
p-value 0.022 0.015 0.009 0.047
VLDL-cholesterol (mgdL−1) 1 19.00± 2.00 20.76± 3.35 18.90± 4.66 18.64± 4.11 0.755
2 16.72± 2.72 22.68± 11.83 16.50± 1.29 16.75± 8.40 0.906
3 13.34± 3.52 29.92± 3.82*‡ 9.53± 2.83†‡ 9.82± 4.27†‡ 0.003
p-value 0.060 0.045 0.009 0.037
C-reactive protein (mgdL−1) 1 42.40± 4.92 41.40± 2.190 44.50± 4.54 43.00± 2.19 0.568
2 49.75± 9.21 47.80± 8.49 45.50± 7.84 45.57± 5.62 0.707
3 41.14± 7.58 54.40± 4.77 50.33± 3.50 43.37± 7.34 0.013
p-value 0.174 0.074 0.260 0.627
Time 1, baseline; time 2: 2 weeks after alloxan injection; time 3, 4 weeks after alloxan injection.
*Indicates a signiﬁcant diﬀerence with non-diabetic control group; †indicates a signiﬁcant diﬀerence with diabetic group; ‡indicates a signiﬁcant
diﬀerence between times 1 and 3.
Table 2. Average size of pancreatic islets in bilberry and gliben-
clamide diabetic treated rats (mean± SEM) (P< 0.05)
Group
Pancreas
islet size (𝜇)
Non-diabetic (n= 8) 1.21± 0.18
Diabetic (n= 8) 0.56± 0.07*
Glibenclamide (n= 8) 1.05± 0.25†
Vaccinium (n= 8) 1.07± 0.39†
P-value 0.005
*Means diﬀer signiﬁcantly from non-diabetic control group †indicates
a signiﬁcant diﬀerence from diabetic group.
among other components of Vaccinium species.15 In addition,
numerous health beneﬁts have been identiﬁed for these phyto-
chemicals, including antioxidant, anti-inﬂammatory, cardiopro-
tective and vision-improving activities.19 Previous investigations
have shown that bilberry fruit containing anthocyanins is useful
for the prevention and treatment of type 2 diabetes.18,20
In the present study, bilberry supplementation elevated serum
insulin levels in alloxan-induced diabetic rats. It has been reported
that anthocyanin stimulates insulin secretion in rodent pancreatic
𝛽 cells in the presence of glucose, and attenuates obesity and
insulin resistance in mice.20,21 In addition, anthocyanins have
𝛼-glucosidase inhibitory activity and can inhibit intestinal absorp-
tionof glucose.22,23 Flavonoids havebeen identiﬁed as antidiabetic
components: Nica et al. demonstrated the role of ﬂavonoids in
mediating the metabolic eﬀects of insulin.24 In addition, it has
been reported that oleanolic acid, a triterpenoid found in the Vac-
cinium genus, increases the release of acetylcholine from nerve
terminals. Acetylcholine stimulates muscarinic M3 receptors in
pancreatic cells and increases the release of insulin.25 Thus oleano-
lic acid is one of the active constituents likely to be responsible for
the observed increases in serum insulin concentrations following
bilberry supplementation.25,26
In the current study, bilberry not only improved hyperglycemia
but also signiﬁcantly attenuated diabetic dyslipidemia by reduc-
ing plasma levels of total cholesterol, LDL-C, VLDL-C and triglyc-
erides. A previous study has indicated the beneﬁcial eﬀects of
Vaccinium treatment on serum lipid proﬁle and oxidative stress
wileyonlinelibrary.com/jsfa © 2015 Society of Chemical Industry J Sci Food Agric 2016; 96: 764–768
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Figure 1. Section of Langerhans islets , H&E staining (40×): (A) diabetic; (B) non-diabetic; (C) treated with glibenclamide; (D) treated with bilberry.
in hyperlipidemic adult patients.27 Anthocyanins may account for
the lipid-modifying eﬀects of bilberry, which act through regulat-
ing theactivity of enzymes involved in lipoproteinmetabolism.21,28
Moreover, ﬁbers such as pectin that are present in bilberry possess
hypolipidemic activity owing to their inhibitory eﬀect on intestinal
absorption of cholesterol and bile acids.29 The plant also contains
phytosterols, which are structurally similar to cholesterol and com-
petitively inhibit intestinal absorption of cholesterol.30
One of the potential clinical beneﬁts of bilberry is its anti-
inﬂammatory eﬀect. Bioﬂavonoids and anthocyanosides present
in bilberry prevent the release and synthesis of pro-inﬂammatory
compounds such as histamine, prostaglandins and leukotrienes.31
Oleanolic acid has also been shown to have anti-inﬂammatory and
hepatoprotective eﬀects.25 In the present study, serum CRP levels
did not change in any of the study groups; however, this might
be due to the lack of signiﬁcant eﬀect of alloxan-induced diabetes
on the development of systemic inﬂammation, as serum CRP was
comparable betweennon-diabetic anddiabetic rats at all assessed
time points of study, i.e. baseline and weeks 2 and 4.
A signiﬁcant improvementwas observed in the histological ﬁnd-
ings of pancreas tissue following supplementation with bilberry.
Plant antioxidants such as alkaloid, terpenoids and sterol have
been shown in previous studies to restore and regenerate pancre-
atic 𝛽 cells and reduce tissue inﬂammation in experimental mod-
els of diabetes.32,33 As mentioned earlier, bilberry contains sev-
eral antioxidant components that can protect against oxidative
stress-induced pancreatic damage via attenuation of membrane
lipid peroxidation and blunting other detrimental eﬀects of free
radicals.29 In addition, the anti-inﬂammatory properties of bilberry
can prevent pancreatic damage induced by alloxan.19,31
CONCLUSIONS
To sum up, ﬁndings of the present experimental study indicated
the anti-hyperglycemic and anti-hyperlipidemic eﬃcacy of bil-
berry fruit in alloxan-induced diabetic rats. It is interesting to note
that the lipid-modifying eﬀects of bilberry included correction
of cholesterol and triglyceride levels, an eﬀect that is particu-
larly important for the treatment of mixed dyslipidemias. Another
important aspect of the present study is the use of crude fruit
without any extraction or processing. Hence, even greater antidi-
abetic and lipid-modifying eﬀects are expected with the use of
bilberry extracts concentrated with the bioactive phytochemicals
of the plant. Further studies are recommended to explore the
J Sci Food Agric 2016; 96: 764–768 © 2015 Society of Chemical Industry wileyonlinelibrary.com/jsfa
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protective eﬀects of bilberry against diet-induced hyperlipidemia.
Finally, given the strong ethno-medicinal background and safety
of bilberry fruit, clinical trials are warranted to evaluate the bene-
ﬁts of dietary supplementation with bilberry in patients with car-
diometabolic disorders.
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